Marcus Weber

Title: The Innovative Contributions of Marcus Weber

Introduction

Marcus Weber is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of opioid receptor agonists. His work focuses on creating innovative solutions that address medical challenges.

Latest Patents

Marcus Weber holds a patent for "Fentanyl derivatives as pH-dependent opioid receptor agonists." This invention relates to fluorinated fentanyl derivatives that function as opioid receptor agonists. These derivatives activate target opioid receptors in a pH-dependent manner, making them selective for receptors in inflamed (acidic) environments. The patent also covers the uses of these derivatives and the pharmaceutical compositions that comprise them. He has 1 patent to his name.

Career Highlights

Throughout his career, Marcus Weber has worked with prestigious institutions, including Charité – Universitätsmedizin Berlin and Konrad Zuse Institute. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical sector.

Collaborations

Marcus has collaborated with notable colleagues, including Christian Zöllner and Olga Scharkoi. These partnerships have further enhanced his research and innovation efforts.

Conclusion

Marcus Weber's work in developing pH-dependent opioid receptor agonists showcases his commitment to advancing medical science. His innovative approach to pharmaceuticals has the potential to improve treatment options for patients in need.